Media Centre

Access our press/media kit

Videos

GDPR at EORTC
Tailoring medicine to patient needs
EORTC: The future of cancer therapy #WeAreEORTC
2019 World Cancer Day

Previous 123 Next

Press Releases

21 Oct 2025

Brain Tumour Group,Genito-Urinary Cancers Group,Head and Neck Cancer Group,News,Press release,Quality of Life Group,Soft Tissue and Bone Sarcoma Group

New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
2 Sep 2025

Press release,Quality of Life Group

New policy review highlights the importance of health-related quality of life in advanced cancer
22 Apr 2025

News,Press release,Quality of Life Group

EORTC Quality of Life Group unveils flexible, future-focused strategy for patient-reported outcome assessment in cancer care
15 Apr 2025

News,Older Adults Council,Press release,Quality of Life Group

EMA-EORTC workshop underscores critical role of patient-reported outcomes and quality of life data in regulatory decision-making

Previous 123 Next

Latest Newsletter

Subscribe to our newsletter

News

Filter on topic

17 Apr 2026

News,Soft Tissue and Bone Sarcoma Group

In Memoriam of Martine Van Glabbeke (1951-2026)
27 Feb 2026

News

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases
27 Feb 2026

News

EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers
26 Feb 2026

Genito-Urinary Cancers Group,News

First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma
4 Feb 2026

News

World Cancer Day: How clinical cancer research changes lives
27 Jan 2026

News,Quality of Life Group

New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events
26 Jan 2026

News

First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG
16 Jan 2026

News

EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology
8 Jan 2026

News,Quality of Life Group

New EORTC quality of life questionnaire for adolescents and young adults with cancer
19 Dec 2025

News

P-Value Workshop

Previous 123 Next

Cookie	Duration	Description
_GRECAPTCHA	5 months 27 days	This cookie is set by Google. In addition to certain standard Google cookies, reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	1 year	This cookies is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.

Cookie	Duration	Description
IDE	1 year 24 days	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie	15 minutes	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
YSC	session	This cookies is set by Youtube and is used to track the views of embedded videos.

Cookie	Duration	Description
cookielawinfo-checkbox-functional	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
ep201	30 minutes	This cookie is set by the provider Surveymonkey. This cookie is used for statistical analysis and website optmization. It gathers information on user's interaction with the SurveyMonkey- Widget on thewebsite.
ep202	3 months	This cookie is set by the provider Surveymonkey. This cookie is used for statistical analysis and website optmization. It gathers information on user's interaction with the SurveyMonkey- Widget on thewebsite.

Media centre

Videos

GDPR at EORTC

Tailoring medicine to patient needs

EORTC: The future of cancer therapy #WeAreEORTC

2019 World Cancer Day

Press Releases

New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

New policy review highlights the importance of health-related quality of life in advanced cancer

EORTC Quality of Life Group unveils flexible, future-focused strategy for patient-reported outcome assessment in cancer care

EMA-EORTC workshop underscores critical role of patient-reported outcomes and quality of life data in regulatory decision-making

Latest Newsletter

Sign up for EORTC Newsletter

News

In Memoriam of Martine Van Glabbeke (1951-2026)

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers

First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma

World Cancer Day: How clinical cancer research changes lives

New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events

First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG

EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology

New EORTC quality of life questionnaire for adolescents and young adults with cancer

P-Value Workshop

Media centre

Videos

GDPR at EORTC

Tailoring medicine to patient needs

EORTC: The future of cancer therapy #WeAreEORTC

2019 World Cancer Day

Press Releases

New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

New policy review highlights the importance of health-related quality of life in advanced cancer

EORTC Quality of Life Group unveils flexible, future-focused strategy for patient-reported outcome assessment in cancer care

EMA-EORTC workshop underscores critical role of patient-reported outcomes and quality of life data in regulatory decision-making

Latest Newsletter

EORTC Newsletter: July 2026 Edition

News

In Memoriam of Martine Van Glabbeke (1951-2026)

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers

First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma

World Cancer Day: How clinical cancer research changes lives

New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events

First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG

EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology

New EORTC quality of life questionnaire for adolescents and young adults with cancer

P-Value Workshop